About Handl Therapeutics
Handl Therapeutics is a company based in Leuven (Belgium) founded in 2019 by Michael Linden was acquired by UCB in November 2020. Handl Therapeutics operates in a competitive market with competitors including Jazz Pharmaceuticals, BridgeBio, Spark Therapeutics, Biogen and Alnylam, among others.
- Headquarter Leuven, Belgium
- Founders Michael Linden
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Handl Therapeutics
Investors in Handl Therapeutics
Handl Therapeutics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include UCB and VLAIO.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Management consulting services are provided to businesses in Belgium.
|
Locked | Locked | Locked | |
|
Therapies for immunological and neurological disorders are developed.
|
Locked | Locked | Locked |
Investor details for Handl Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Handl Therapeutics
Investment portfolio details for Handl Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Handl Therapeutics
Detailed financials for Handl Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Handl Therapeutics Comparisons
Peer comparison for Handl Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Handl Therapeutics
Handl Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, BridgeBio, Spark Therapeutics, Biogen and Alnylam, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| Locked | Locked | Locked |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| Locked | Locked | Locked |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| Locked | Locked | Locked |
RNA interference-based therapeutics are developed for multiple disorders.
|
|
| Locked | Locked | Locked |
A biopharmaceutical company accelerating innovative mental health treatments.
|
Detailed competitors of Handl Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Handl Therapeutics
Complete news archive for Handl Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Handl Therapeutics
Handl Therapeutics was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Handl Therapeutics is headquartered in Leuven, Belgium. It is registered at Leuven, Flemish Brabant, Belgium.
Handl Therapeutics was founded in 2019 and is headquartered in Leuven, Belgium. Focus is placed on the development of in vivo gene therapies targeting central nervous system diseases. Proprietary adeno-associated virus capsid technology is utilized to address neurodegenerative conditions. Operations center on advancing therapeutic solutions within the biotechnology sector, with emphasis on clinical and preclinical research for CNS applications.
Handl Therapeutics's top competitors include Jazz Pharmaceuticals, Spark Therapeutics and BridgeBio.